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Endocytosis is a fundamental process of eukaryotic
cells that is critical for nutrient uptake, signal trans-
duction, and growth.We have developed amolecular
probe to quantify endocytosis. The probe is a lipid
conjugated to a fluorophore that is masked with an
enzyme-activatable moiety known as the trimethyl
lock. The probe is not fluorescent when incorporated
into the plasma membrane of human cells but
becomes fluorescent upon internalization into endo-
somes, where cellular esterases activate the tri-
methyl lock. Using this probe, we found that human
breast cancer cells undergo constitutive endocytosis
more rapidly than do matched noncancerous cells.
These data reveal a possible phenotypic distinction
of cancer cells that could be the basis for chemother-
apeutic intervention.
INTRODUCTION
Endocytosis is the key regulator of macromolecular internaliza-
tion into eukaryotic cells (Conner and Schmid, 2003). In this intri-
cate process, proteins mediate the invagination of the plasma
membrane and then its fusion to pinch off a lipid-bilayer-encased
vesicle within a cell (Doherty and McMahon, 2009). Many endo-
cytic pathways operate in parallel. The most-studied pathway,
clathrin-mediated endocytosis, occurs constitutively in all cell
types and generally involves the binding of a ligand to a receptor
prior to internalization (McMahon and Boucrot, 2011). Another
pathway, caveolae-mediated endocytosis, is characterized by
vesicles enriched in glycosphingolipids, cholesterol, and the
integral membrane protein caveolin (Hansen and Nichols,
2009). These endocytic pathways are the portals for delivery of
essential nutrients, such as iron via transferrin and cholesterol
via lipoprotein particles. Deleteriously, these pathways can facil-
itate the transit of pathogens (Gruenberg and van der Goot,
2006; Kerr and Teasdale, 2009).
Endocytosis regulates the concentration of cell-surface
receptors by transporting them to and from the plasma mem-
brane (Mosesson et al., 2008). Accordingly, endocytosis has a
direct influence on signal transduction pathways that can mal-
function in cancer patients (Hanahan and Weinberg, 2011).
Conversely, differences in endocytosis between cancerous
and noncancerous cells could lead to new treatment options.614 Chemistry & Biology 20, 614–618, April 18, 2013 ª2013 ElsevierFor example, pancreatic-type ribonucleases (ptRNases) have
emerged as putative cancer chemotherapeutic agents (Lee
and Raines, 2008; Arnold, 2008; Fang and Ng, 2011; Lomax
et al., 2012). These cationic enzymes are internalized by recep-
tor-independent endocytosis and then escape from endosomes
to the cytosol, where they catalyze the degradation of cellular
RNA. The basis for their cancer-cell-specific toxicity is not clear,
but could entail differential rates of endocytosis.
Two types of assays have been used to monitor constitutive
endocytosis (Ivanov, 2007). In one, endocytosis has been quan-
tified by assaying the uptake of soluble enzymes, such as horse-
radish peroxidase (Steinman andCohn, 1972). Data are acquired
by fixing cells and then staining them with a colorimetric sub-
strate. This assay is discontinuous and vulnerable to the artifacts
that can accompany the use of fixed cells (Richard et al., 2003).
Alternatively, the fate of a fluorescent lipid has been monitored
continuously by microscopy (Kok et al., 1990; Cochilla et al.,
1999; Maier et al., 2002; Rea et al., 2004; Bissig et al., 2012).
These assays require extensive washing to remove unincorpo-
rated lipid and are not amenable to automated cell counting
and sorting techniques.
We sought to develop a facile means to assess endocytosis
continuously in live cells. An ideal molecular probe would have
no background fluorescence and would be able to distinguish
the lumen of endosomes from the plasma membrane. We
reasoned that a lipid with a head group that is responsive to an
endosomal enzyme could serve as the basis as such a probe,
as fluorescence generated over time would reflect the rate of
endocytosis. Here, we report on the efficacy of our strategy.RESULTS AND DISCUSSION
To test our strategy, we designed lipid 1. Lipid 1 contains a
‘‘trimethyl lock’’ moiety in which an acetyl ester acts as a molec-
ular trigger (Levine and Raines, 2012). This ester linkage is known
to be stable to hydrolysis at physiological pH (Chandran et al.,
2005; Lavis et al., 2006a, 2006b; Levine et al., 2008). Although
the ester linkage in lipid 1 is insulated from the fluorophore, its
hydrolysis is coupled to the cleavage of its otherwise recalcitrant
amide bond. Analogous probes have been used to quantify the
endocytosis of soluble molecules (Johnson et al., 2007; Mangold
et al., 2008; Turcotte et al., 2009; Chao et al., 2010; Chao and
Raines, 2011), but not membrane-associated ones. Our expec-
tation here was that upon endocytosis, the head group of lipid
1 would encounter endosomal esterases (Tian et al., 2012).
The ensuing hydrolysis of the acetyl ester would unmask the
rhodamine moiety and label the lumen with fluorescenceLtd All rights reserved
Figure 1. Structure and Function of Lipid 1
Fluorescence is unmasked by an esterase
encountered upon endocytosis.
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route ending with the conjugate addition of 1,2-dihexadeca-
noyl-sn-glycero-3-phosphothioethanol to a trimethyl lock-
rhodamine-maleimide fragment.
The phosphatidylglycerol moiety of lipid 1 is endogenous
to humans and incorporates spontaneously into cellular
membranes (Christie and Han, 2010). Most importantly for us,
incorporated lipid 1 paints HeLa cells incubated at 37C with a
punctate staining pattern, as shown in Figure 2A. This pattern
is indicative of vesicular localization and demonstrates that lipid
1 does indeed report on constitutive endocytosis. Notably, no
fluorescence was observed in cells incubated at 4C (Figure 2B),
a temperature that does not allow for endocytosis (Tomoda et al.,
1989).
Endocytic pathways are complex (Bissig et al., 2012). What
then is the fate of lipid 1 after endocytosis? As shown in
Figure 3A, we found that lipid 1 does not colocalize with fluores-
cently labeled transferrin, which is a marker of recycling
endosomes (Ghosh et al., 1994). Consistent with this finding,
lipid 1 that had been unmasked by a cellular esterase does not
reappear on the plasma membrane (Figure 3B). These data indi-
cate that lipid 1 does not recycle to the plasma membrane, but
instead enters endosomes and traffics to other destinations.
This attribute is desirable because fluorescence from lipid 1 re-
ports only on new endocytic events (and not repetitious entry).
As shown in Figure 3C, we found that lipid 1 does colocalize
partially with LysoTracker red, a marker of late endosomes or
lysosomes (Zhang et al., 1994), evincing its joining the canonical
endosome-to-lysosome pathway along with trafficking to other
subcellular compartments.
Lipid 1 can report on the rate of endocytosis. HeLa cells were
labeled at 4Cwith lipid 1 and then incubated for various times at
37C. Fluorescence was quantified by flow cytometry. As shown
in Figure 4, the mean fluorescence per cell increases over time
until 2 hr. This time course is consistent with morphological
observations of mouse fibroblasts, which were seen engulfing
their cell surface every 125 min (Steinman et al., 1976).
Finally, lipid 1 can reveal differences in endocytic rates
between similar cells. HTB-125 and HTB-126 are noncancerous
and cancerous breast cell lines that were derived from the sameChemistry & Biology 20, 614–618, April 18, 2013patient (An et al., 2008). We used lipid 1 to
assess endocytosis by cells in these
matched lines, quantifying the results by
flow cytometry. As shown in Figure 5,
the increase in fluorescence over 3 hr of
incubation at 37C was 2.5-fold for
HTB-125 cells. This increase was less
than half that for HTB-126, which was
6.0-fold. Thus, in these cell lines, endocy-
tosis is significantly more rapid in the
cancerous than in the noncancerous
cells. These differential rates could reflect
more rapid turnover of cell-surface re-ceptors in cancer cells (Mayor and Pagano, 2007), promoting a
cancerous phenotype (Mosesson et al., 2008). We note that
such an intrinsic difference in endocytic rate could provide an
opportunity for therapeutic intervention by increasing the relative
uptake of ptRNases or othermacromolecular drugs (Sahay et al.,
2010; Stephan and Irvine, 2011; Hymel and Peterson, 2012).
SIGNIFICANCE
We have designed and synthesized a head-group-modified
lipid that can be incorporated into the plasma membrane,
and that becomes fluorescent upon initiation of endocy-
tosis. The lipid is trafficked to late endosomes and lyso-
somes and does not enter the recycling endosomal
pathway. The increase in fluorescence can be monitored
over time by flow cytometry and is utilized to reveal that
cells from a breast cancer line undergo endocytosis more
rapidly than do matched noncancerous cells. These data
enable and encourage the use of lipid 1 in the exploration
of endocytosis.
EXPERIMENTAL PROCEDURES
General
All reagents, unless noted, were from Aldrich Chemical (Milwaukee, WI) or
Fisher Scientific (Hanover Park, IL), and were used without further purification.
Thin-layer chromatography was performed by using aluminum-backed plates
coated with silica gel containing F254 phosphor and was visualized by UV illu-
mination or developed with ceric ammonium molybdate stain. Flash chroma-
tography was performed on open columns with silica gel-60 (230–400 mesh).
Nuclear magnetic resonance (NMR) spectra (see Supplemental Information)
were obtained with a Bruker DMX-400 Avance spectrometer at the National
Magnetic Resonance Facility at Madison. Mass spectrometry was performed
with an Applied Biosystems MDS SCIEX 4800 matrix-assisted laser de-
sorption/ionization (MALDI) time-of-flight mass spectrometer at the Mass
Spectrometry Facility in the Biotechnology Center, University of Wisconsin–
Madison.
The term ‘‘concentrated under reduced pressure’’ refers to the removal of
solvents and other volatile materials using a rotary evaporator at water aspi-
rator pressure (<20 mm Hg) while maintaining the water-bath temperature
below 50C. The term ‘‘high vacuum’’ refers to vacuum (<0.1mmHg) achieved
by a mechanical belt-drive oil pump.ª2013 Elsevier Ltd All rights reserved 615
Figure 3. Lipid 1 Does Not Recycle to the Cell Surface
(A–C) HeLa cells in serum-free DMEM were labeled for 3 hr at 4C with lipid
1 (20 mM), washed with serum-free medium, and then incubated for 3 hr
at 37C.
(A) Image after an Alexa Fluor 594 transferrin conjugate (1 mM) was added for
the final 1 hr of a 3 hr incubation.
(B) Image after a 24 hr incubation.
(C) Image after LysoTracker red (50 nM) was added for the final 20 min of a 3 hr
incubation.
Blue, Hoechst 33342. Scale bars represent 20 mm.
Figure 2. Lipid 1 Reports on Endocytosis
HeLa cells in serum-free Dulbecco’s modified Eagle’s medium (DMEM) were
labeled for 3 hr at 4C with lipid 1 (20 mM), washed with serum-free medium,
and then incubated for 3 hr at (A) 37C or (B) 4C. Left: Confocal images. Right:
Overlay of confocal and bright-field images. Blue dye, Hoechst 33342. Scale
bars represent 20 mm.
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Maleimidourea-Rh110 trimethyl lock (20 mg, 0.026 mmol) was synthesized as
described previously (Lavis et al., 2006a) and dissolved in anhydrous chloro-
form (5ml). The resulting solution was added to a flame-dried 10ml round-bot-
tom flask that had been flushed with Ar(g). Anhydrous triethylamine (20 ml,
0.14 mmol) was added, followed by 1,2-dihexadecanoyl-sn-glycero-3-phos-
phothioethanol, sodium salt (Avanti Polar Lipids, Alabaster, AL; 20 mg,
0.027mmol). The flask was covered in foil, and the reaction mixture was stirred
for 3 hr under Ar(g). Reaction progress was monitored by thin-layer chroma-
tography (10% v/v methanol in dichloromethane [DCM]). Once the reaction
was complete, the solvent was evaporated under reduced pressure and the
residue was placed under high vacuum overnight. The crude product was
purified by silica gel chromatography (10%–15% v/vmethanol in DCM) to yield
1 as a white powder (26 mg, 66%). 1H NMR (400 MHz, CDCl3) d: 8.52 (bs, 1H),
7.94 (d, J = 6.3 Hz, 1H), 7.79 (s, 1H), 7.64–7.50 (m, 2H), 7.39 (s, 2H), 7.05
(d, J = 6.9 Hz, 1H), 6.97 (bs, 1H), 6.76 (s, 1H), 6.64–6.56 (m, 2H), 6.51
(t, J = 7.2 Hz, 2H), 6.13 (s, 1H), 5.20 (s, 1H), 4.35 (d, J = 10.8 Hz, 1H),
4.15–3.86 (m, 6H), 3.52–3.40 (m, 2H), 3.24–2.92 (m, 7H), 2.87–2.75 (m, 1H),
2.63–2.57 (m, 2H), 2.41 (s, 3H), 2.34 (s, 3H), 2.28–2.15 (m, 7H), 1.64 (s, 6H),
1.56–1.46 (m, 4H), 1.33–1.14 (m, 48H), 0.87 (t, J = 6.2 Hz, 6H) ppm. 13C
NMR (100 MHz, CDCl3) d: 178.5, 175.4, 174.0, 173.7, 172.1, 170.4, 170.0,
156.0, 153.0, 151.8, 151.7, 150.1, 142.5, 140.1, 139.0, 137.3, 135.4, 133.2,
133.1, 129.9, 128.3, 126.5, 125.0, 124.2, 123.5, 115.4, 114.7, 114.0, 111.6,
107.6, 106.0, 83.6, 70.6, 65.3, 63.9, 62.9, 50.9, 40.3, 39.6, 37.0, 36.5, 34.4,
34.2, 32.1, 30.2–29.2, 27.1, 26.7, 25.7, 25.1, 25.0, 22.8, 22.0, 20.3, 14.3
ppm. 31P NMR (162 MHz, CDCl3) d: 1.7 ppm. MS (MALDI): m/z 1487.75
[M+Na]+ ([C80H113O17N4NaPS]
+ = 1,487.75).
Mammalian Cell Culture
HeLa, HTB-125, and HTB-126 cells were from the American Type Culture
Collection (ATCC) (Manassas, VA). HeLa cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM) containing fetal bovine serum (FBS;
10% v/v), penicillin (100 U/ml), and streptomycin (100 mg/ml). HTB-125 cells
were grown in Hybri-Care Medium supplemented with sodium bicarbonate
(1.5 g/L), mouse epidermal growth factor (30 ng/ml), FBS (10% v/v), penicillin
(100 U/ml), and streptomycin (100 mg/ml). HTB-126 cells were cultured in
DMEM supplemented with bovine insulin (10 mg/ml), FBS (10% v/v), peni-
cillin (100 U/ml), and streptomycin (100 mg/ml). Media and supplements
were from Invitrogen (Carlsbad, CA), Sigma-Aldrich (Milwaukee, WI), or
ATCC. Cells were cultured at 37C in a humidified incubator containing
CO2 (g) (5% v/v).616 Chemistry & Biology 20, 614–618, April 18, 2013 ª2013 ElsevierMicroscopy
Imaging was performed with an Eclipse TE2000-U laser scanning confocal mi-
croscope fromNikon (Tokyo, Japan) equippedwith an AxioCamdigital camera
from Carl Zeiss (Oberkochen, Germany). A blue-diode laser was used to pro-
vide excitation at 408 nm, and emission light was passed through a 35 nm
band-pass filter centered at 450 nm. An argon-ion laser was used to provide
excitation at 488 nm, and emission light was passed through a 40 nm band-
pass filter centered at 515 nm. A HeNe laser was used to provide excitation
at 543 nm, and emission light was passed through a 75 nm band-pass filter
centered at 605 nm.
HeLa cells were plated 24 hr prior to experiments at a density of 13 105 cells
in 1-cm-diameter glass-bottom dishes from Electron Microscopy Sciences
(Hatfield, PA) in 1 ml of medium. On the day of an experiment, all cells, media,
and pipette tips were precooled to 4C for 2 hr. Next, cells were washed with
serum-free DMEM (33 1 ml). Stock solutions of lipid 1 (50 mM in DMSO) were
diluted to 10 mM with absolute ethanol. From this stock, 1 ml was added to
500 ml of serum-free DMEM, which was then vortexed vigorously and applied
to the HeLa cells. Vehicle-treated cells were treated with 500 ml of serum-free
DMEMcontaining 1 ml of ethanol. The labeling reactionwas allowed to proceed
for 3 hr at 4C, after which the cells were washed with serum-free DMEM
(3 3 1 ml). Cells were incubated for the given amount of time at 37C. Lyso-
Tracker red (50 nM) from Invitrogen was used to stain acidic vesicles for the
final 20min of incubation at 37C. Endocytic marker Alexa Fluor 594 transferrin
(1 mM) from Invitrogen was used to stain recycling endosomes for the final 1 hr
of incubation at 37C. Nuclear counterstaining was performed with Hoechst
33342 (2 mg/ml) from Invitrogen for the final 5 min at 37C. Cells were washed
with serum-free DMEM prior to imaging.Ltd All rights reserved
Figure 4. Time Course of Endocytosis by HeLa Cells
HeLa cells in serum-free DMEMwere labeled for 3 hr at 4Cwith lipid 1 (20 mM),
washed with serum-free medium, and incubated for various times at 37C.
Fluorescence was quantified by flow cytometry. Values in arbitrary units (AU)
are the mean ±SD from assays of 10,000 cells.
Figure 5. Rate of Endocytosis Is Greater in Cancerous Cells
Matched breast cell lines HTB-125 (noncancerous) and HTB-126 (cancerous)
in serum-free DMEM were labeled for 3 hr at 4C with lipid 1 (20 mM), washed
with serum-free medium, and incubated for 0 or 3 hr at 37C. Fluorescence
was quantified by flow cytometry. Values are the mean ±SD from triplicate
assays of 2,000 cells. HTB-125 cells: 3.7 ± 0.7 and 9.4 ± 0.7 AU; HTB-126:
3.1 ± 0.6 and 18.6 ± 2.2 AU.
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Flow cytometry was performed at the University of Wisconsin Carbone Cancer
Center with a FACSCalibur instrument equipped with a 488 argon-ion air-
cooled laser from Becton Dickinson (Franklin Lakes, NJ). Fluorescence emis-
sion light was passed through a 30 nm band-pass filter centered at 530 nm.
Cell lines were plated 24 hr prior to experiments at a density of 3 3 105
HeLa cells and 3.7 3 104 cells HTB-125 or HTB-126 cells in 6 ml of medium
(vide supra) in T-25 tissue culture flasks from BD Biosciences (San Jose,
CA). On the day of an experiment, all cells, media, and pipette tips were
precooled to 4C for 2 hr. Next, the cells were washed with serum-free
DMEM (3 3 1 ml). Stock solutions of lipid 1 (50 mM in DMSO) were diluted
with absolute ethanol to 10 mM. This stock solution in ethanol was added to
serum-free DMEM to a final concentration of 20 mM and was mixed vigorously
by vortexing. The medium was removed from the cells and was replaced with
1 ml of the labeling solution. Vehicle-treated cells were treated with 1 ml of
serum-free DMEM containing 2 ml of ethanol. The labeling reaction was al-
lowed to proceed for 3 hr at 4C, after which the cells were washed with
serum-free DMEM (3 3 1 ml). Cells were incubated for a known time at
37C. Cells were then washed with Dulbecco’s PBS (DPBS; 1 ml; Invitrogen)
and treated with trypsin/EDTA (0.25% w/v; 750 ml) for 5 min at 37C. The
trypsin was neutralized with DMEM containing FBS (10% v/v; 750 ml), and
the cells were collected by centrifugation (5 min at 400 3 g). The supernatant
was decanted, and the cell pellet was resuspended in 1 ml of DPBS. The cells
were collected again by centrifugation (5 min at 4003 g). The supernatant was
decanted, and the pellet was resuspended and fixed with 100 ml of aqueous
formaldehyde (2% v/v) for 30 min in a vial covered with aluminum foil. This so-
lution was diluted by adding DPBS to 1 ml, and the cells were collected by
centrifugation (5 min at 400 3 g). The supernatant was decanted, and the
cell pellet was resuspended in 1 ml of DPBS. The suspension was strained
through a 35 mm filter into a polystyrene flow cytometry test tube from BD Bio-
sciences. The fixed cells were stored on ice until analyzed (1–4 hr). Themean
fluorescence per cell was determined in triplicate for 10,000 HeLa cells, 2,000
HTB-125 cells, and 2,000 HTB-126 cells, and the data were analyzed with
FlowJo software from Tree Star (Ashland, OR).
SUPPLEMENTAL INFORMATION
Supplemental Information includes a 1H, 13C, and 31P NMR spectrum of lipid 1
and can be found with this article online at http://dx.doi.org/10.1016/j.
chembiol.2013.03.016.
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